Shutterstock.com_1714981606/Nadya So

12 August 2025Reinsurance

Life insurance applicants increasingly using longevity drugs, warns Swiss Re

Repurposed drugs used for longevity are gaining popularity, according to global reinsurance group Swiss Re, prompting it to introduce guidance for underwriters on how to assess life insurance applicants who show signs of their use.

Already registered?

Login to your account

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Conduit Re pivots to resilience as wildfire lessons reshape retro strategy

13 May 2026 CEO backs strategy to ‘eradicate basis risk’ after ‘California issue in 2025’.

Conduit Re grows premiums as it pulls back risk in a softening market

13 May 2026 First-quarter GWP rose 4.9%, leaned into casualty after heavy wildfire losses.

OnRe hires former Fidelis executive as chief underwriting officer

13 May 2026 Bermuda-based reinsurer oversees $170m through onchain capital platform.

More articles

Talanx sets record Q1 net income of €774m, insurance result up 34%

Zurich CEO senses durable commercial insurance rate turnaround in Q1

Zurich taps data centre surge for commercial premium boost

Allianz grows Q1 P&C book 6.8%, improves combined ratio

Conduit Re pivots to resilience as wildfire lessons reshape retro strategy

Cyber now ranks as top UK business risk

Conduit Re grows premiums as it pulls back risk in a softening market

Perils increases windstorm Nils loss estimate by €181m

Copyright © intelligentinsurer.com 2024 | Headless Content Management with Blaze